Article
Electrochemical Nanoreactor Provides a Comprehensive View of Isocitrate Dehydrogenase Cancer-drug Kinetics.
Angewandte Chemie (International ed. in English) - 16 Oct 2023
Herold Ryan A, Schofield Christopher J, Armstrong Fraser A
Abstract excerpt
The ability to control enzyme cascades entrapped in a nanoporous electrode material (the "Electrochemical Leaf", e-Leaf) has been exploited to gain detailed kinetic insight into the mechanism of an anti-cancer drug. Ivosidenib, used to treat acute myeloid leukemia, acts on a common cancer-linked variant of isocitrate dehydrogenase 1 (IDH1 R132H) inhibiting its "gain-of-function" activity-the undesired reduction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
